Empowering all doctors to provide the best possible care.
Free trial 👉 https://t.co/84gYhWexam
Privacy policy 👉 https://t.co/FNt5UZ8y2P
Apr 13, 2023 • 8 tweets • 3 min read
1/In this RCT, continuous IV hydrocortisone significantly lowered the risk of death in patients with severe CAP compared to placebo. Welcome to our weekly #OMTweetorial. #MedTwitter#MedEd#EBM#JournalClub
2/In this pre-COVID government-funded trial in @NEJM, Pierre-François Dequin et al assessed whether a continuous hydrocortisone infusion reduced mortality in patients with severe CAP.